Yingxiang Gao

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Beijing Innocare Pharma Tech Co., Ltd., Guangzhou Innocare Pharma Tech Co., Ltd.. Active years: 2018-2025.

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 90.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Shanghai, CN (2018)
Jiangsu, CN (2021)
Beijing, CN (2019 - 2023)
Nanjing, CN (2020 - 2023)

Company Filing History:

6 out of 15

Beijing Innocare Pharma Tech Co., Ltd.

patents

4 out of 6

Guangzhou Innocare Pharma Tech Co., Ltd.

patents

Years Active: 2018-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391666 - Indoline-1-formamide compound, preparation method therefor, and medical use thereof (2025-08-19),

2. 12162873 - Substituted nicotinimide inhibitors of BTK for treating cancer (2024-12-10),

3. 11840513 - Substituted nicotinimide inhibitors of BTK for treating cancer (2023-12-12),

4. 11572353 - Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof (2023-02-07),

5. 11345695 - Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease (2022-05-31),

6. 11059805 - Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof (2021-07-13),

7. 11046682 - Fused heterocyclic derivatives, their preparation methods thereof and medical uses thereof (2021-06-29),

8. 10710981 - Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof (2020-07-14),

9. 10301297 - Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease (2019-05-28),

10. 9951056 - Substituted nicotinamide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease (2018-04-24),

Title: Yingxiang Gao: Pioneering Inventor from Beijing

Introduction: Yingxiang Gao is a distinguished inventor hailing from Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Gao's recent patents focus on advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we perceive transportation technology.

Career Highlights: With over two decades of experience in the tech industry, Gao has held key positions in leading research institutions and tech companies, driving forward cutting-edge projects and inventions.

Collaborations: Throughout his career, Gao has collaborated with top engineers, researchers, and inventors globally, fostering a culture of innovation and knowledge exchange in the tech community.

Conclusion: Yingxiang Gao's relentless pursuit of innovation and his remarkable contributions to the tech industry continue to inspire future generations of inventors and researchers worldwide.